James A Wilkins

Title: Innovations of James A. Wilkins in Biochemistry

Introduction

James A. Wilkins is a notable inventor based in San Mateo, CA (US). He has made significant contributions to the field of biochemistry, particularly in the area of peptide cleavage processes. His work has implications for the isolation of human relaxin, a hormone involved in various physiological processes.

Latest Patents

James A. Wilkins holds a patent for "Processes and compositions for the isolation of human relaxin." This patent describes a process for cleaving a polypeptide into at least two components. The method involves treating a reduced, free-cysteine form of the polypeptide with a cleaving agent under specific conditions. The process is designed to cleave the polypeptide at a desired junction, allowing for the effective isolation of relaxin peptides.

Career Highlights

Wilkins has been associated with Genentech, Inc., a leading biotechnology company known for its innovative approaches to drug development. His work at Genentech has allowed him to contribute to advancements in therapeutic solutions, particularly in the realm of peptide-based treatments.

Collaborations

Throughout his career, James A. Wilkins has collaborated with esteemed colleagues such as Dennis J. Henner and Richard L. Vandlen. These collaborations have fostered a productive environment for research and innovation in biochemistry.

Conclusion

James A. Wilkins exemplifies the spirit of innovation in the field of biochemistry through his patented processes for peptide cleavage. His contributions continue to influence the development of therapeutic applications in medicine.